Dr Linda Rieswijk, Ph.D. (L.)
Key publications
-
Phillips, R. V., Rieswijk, L., Hubbard, A. E., Vermeulen, R., Zhang, J., Hu, W., Li, L., Bassig, B. A., Wong, J. Y. Y., Reiss, B., Huang, Y., Wen, C., Purdue, M., Tang, X., Zhang, L., Smith, M. T., Rothman, N., & Lan, Q. (2019). Human exposure to trichloroethylene is associated with increased variability of blood DNA methylation that is enriched in genes and pathways related to autoimmune disease and cancer. Epigenetics, 14(11), 1112-1124. https://doi.org/10.1080/15592294.2019.1633866More information about this publication
-
Luderer, U., Eskenazi, B., Hauser, R., Korach, K. S., McHale, C. M., Moran, F., Rieswijk, L., Solomon, G., Udagawa, O., Zhang, L., Zlatnik, M., Zeise, L., & Smith, M. T. (2019). Proposed Key Characteristics of Female Reproductive Toxicants as an Approach for Organizing and Evaluating Mechanistic Data in Hazard Assessment. Environmental Health Perspectives, 127(7), Article 075001. https://doi.org/10.1289/EHP4971More information about this publication
-
AstraZeneca-Sanger Drug Combination DREAM Consortium (2019). Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen. Nature Communications, 10(1), Article 2674. https://doi.org/10.1038/s41467-019-09799-2More information about this publication
-
Guyton, K. Z., Rieswijk, L., Wang, A., Chiu, W. A., & Smith, M. T. (2018). Key Characteristics Approach to Carcinogenic Hazard Identification. Chemical Research in Toxicology, 31(12), 1290-1292. https://doi.org/10.1021/acs.chemrestox.8b00321More information about this publication
-
Nymark, P., Rieswijk, L., Ehrhart, F., Jeliazkova, N., Tsiliki, G., Sarimveis, H., Evelo, C. T., Hongisto, V., Kohonen, P., Willighagen, E., & Grafstrom, R. C. (2018). A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions. Toxicological Sciences, 162(1), 264-275. https://doi.org/10.1093/toxsci/kfx252More information about this publication
-
Moodley, K., Rieswijk, L., Oprea, T. I., & Dumontier, M. (2017). Assessing the quality of manually curated drug indication and usage information via ontology term mappings. Paper presented at Bio-Ontologies, Prague, Czech Republic.More information about this publication
-
Rieswijk, L., Brauers, K. J. J., Coonen, M. L. J., Jennen, D. G. J., van Breda, S. G. J., & Kleinjans, J. C. S. (2016). Exploiting microRNA and mRNA profiles generated in vitro from carcinogen-exposed primary mouse hepatocytes for predicting in vivo genotoxicity and carcinogenicity. Mutagenesis, 31(5), 603-615. https://doi.org/10.1093/mutage/gew027More information about this publication
-
Rieswijk, L., Claessen, S. M. H., Bekers, O., van Herwijnen, M., Theunissen, D. H. J., Jennen, D. G. J., de Kok, T., Kleinjans, J. C. S., & van Breda, S. G. J. (2016). Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma. Toxicology, 350, 31-39. https://doi.org/10.1016/j.tox.2016.05.002More information about this publication
-
Rieswijk, L. (2016). MicroRNAs and epigenetics in chemical carcinogenesis : an integrative toxicogenomics-based approach. [Doctoral Thesis, Maastricht University]. Uitgeverij BOXPress. https://doi.org/10.26481/dis.20160120lrMore information about this publication
-
Rieswijk, L., Brauers, K. J. J., Coonen, M. L. J., Van Breda, S. G. J., Jennen, D. G. J., & Kleinjans, J. C. S. (2015). Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes. Mutagenesis, 30(6), 771-784. https://doi.org/10.1093/mutage/gev036More information about this publication
Recent publications
Other publications
For publications see my ORCID profile http://orcid.org/0000-0002-6106-1347